mainstay

Mainstay Medical’s ReActiv8-B Clinical Trial for treatment of Chronic Low Back Pain enrols First Subject

on 14/09/2016 10:35
Trial to gather data in support of an application for US pre-market approval (PMA)
Read more

Mainstay Medical announces € 30 million fundraising

on 17/06/2016 12:43
New capital to support European Commercialisation and US PMA clinical trial
Read more

Mainstay Medical full year 2015 preliminary results and business update

on 16/02/2016 14:15

Additional data confirm positive results for Clinical Trial of ReActiv8®

on 04/12/2015 10:24
Additional data confirm clinically important, statistically significant, and lasting improvement in pain, disability, and quality of life for people with Chronic Low Back Pain and limited treatment options
Read more

Mainstay Medical – Interim Management Statement

on 09/11/2015 11:45